Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 2.

Summary of Clinical Studies Investigating the Bile Acid Profiles and Fecal Microbiota in Irritable Bowel Syndrome

Study Participants (n) Fecal BA profile Fecal microbiota
Wong et al (2012)139 HC (26), IBS-C (26), and IBS-D (26)

Higher total BA in IBS-D than in IBS-C but not than in HC

Total BA correlated with stool weight and fat

Not investigated
Duboc et al (2012)16 HC (18) and IBS-D (14)

Similar total BA in IBS-D and HC

Increased PBA (%) and decreased SBA (%) in IBS-D than in HC

Decreased the leptum and Bifidobacterium groups in IBS-D than in HC

Increased E. coli species in IBS-D than in HC

Shin et al (2013)140 HC (30), IBS-C (30), and IBS-D or FD (31)

Increased total UBA in IBS-D than in IBS-C but not than in HC

Higher primary UBA (%) in IBS-D than in HC

Lower secretory CDCA and DCA (%) in IBS-C than in HC

Higher non-secretory secondary LCA (%) in IBS-C than in HC

Not investigated
Dior et al (2016)36 HC (15), IBS-C (15), and IBS-D (16)

No differences of total BAs among the three groups

Increased PBAs and decreased SBAs in IBS-D compared to HC

Increased sulfated BAs and UDCA in IBS-D compared to HC

Increased CDCA, sulfated BAs, and UDCA in IBS-D compared to IBS-C

No differences in the total fecal bacteria counts in the 3 groups

Increased relative counts of E. coli in IBS-D compared to HC

Increased relative counts of Bacteroides and Bifidobacterium in IBS-C compared to IBS-D and HC

Zhao et al (2020)137 HC (89) and IBS-D (290)

Increased total BA in IBS-D than in HC

Increased amounts of CA, CDCA, DCA, LCA, 7-KDCA, UDCA, and ωMCA and increased % of CA, CDCA, UDCA, and 7-KDCA and decreased % of LCA and 12-KLCA in IBS-D with high BA excretion compared with HC

Increased abundances of Clostridia bacteria, Bifidobacterium, Escherichia, and Bilophila and decreased abundances of Alistipes and Bacteroides in IBS-D with high fecal BA excretion

Positive correlation of the abundances of Clostridia genera and C. scindens species with total BAs and serum C4

Wei et al (2020)136 HC (28) and IBS-D (55)

Increased total fecal BA in IBS-D than in HC

Increased PBAs and decreased SBAs in IBS-D than in HC

Decreased LCA in IBS-D than in HC

Increased CBAs, UBAs, and ratio of CBAs/UBAs in IBS-D

Increased Proteobacteria, Gammaproteobacteria, Enterobacteriales, and Enterobacteriaceae and decreased Clostridia, Clostridiales, and Ruminococcaceae in IBS-D

Decreased 9 genera including 5 from Ruminococcaceae in IBS-D

Negative correlation of PBAs and positive correlation of SBAs with 8 genera among decreased 9

Wei et al (2021)138 HC (32) and IBS-D (52)

Increased total fecal BA in IBS-D than in HC

Increased PBAs and decreased SBAs in IBS-D than in HC

Not investigated
James et al (2021)141 HC (97), IBS-D (52), and IBS-C (24)

Increased CA in IBS-D than in HC but not in IBS-C

Increased CDCA in IBS-D than in IBS-C and in HC

Decreased GCA in IBS-C than in IBS-D and in HC

Not investigated

BA, bile acid; HC, healthy control; IBS-C, constipation-predominant irritable bowel syndrome; IBS-D, diarrhea-predominant irritable bowel syndrome; PBA, primary bile acid; SBA, secondary bile acid; E. coli, Escherichia coli; FD, functional diarrhea; UBA, unconjugated bile acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; LCA, lithocholic acid; UDCA, ursodeoxycholic acid; CA, cholic acid; 7-KDCA, 7-ketodeoxycholic acid; ωMCA, ω-muricholic acid; 12-KLCA, 12-ketolithocholic acid; C. scindens, Clostridium scindens; C4, 7α-hydroxy-4-cholesten-3-one; CBA, conjugated bile acid; GCA, glyco-CA.

J Neurogastroenterol Motil 2022;28:549~561 https://doi.org/10.5056/jnm22129
© J Neurogastroenterol Motil